Atai Life Sciences EBIT 2020-2024 | ATAI
Atai Life Sciences ebit from 2020 to 2024. Ebit can be defined as earnings before interest and taxes.
| Atai Life Sciences Annual EBIT (Millions of US $) |
|
|---|---|
| 2024 | $-103 |
| 2023 | $-125 |
| 2022 | $-145 |
| 2021 | $-136 |
| 2020 | $-104 |
| 2019 | $-18 |
| Atai Life Sciences Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-30 |
| 2024-09-30 | $-23 |
| 2024-06-30 | $-26 |
| 2024-03-31 | $-24 |
| 2023-12-31 | $-34 |
| 2023-09-30 | $-27 |
| 2023-06-30 | $-32 |
| 2023-03-31 | $-33 |
| 2022-12-31 | $-38 |
| 2022-09-30 | $-38 |
| 2022-06-30 | $-35 |
| 2022-03-31 | $-33 |
| 2021-12-31 | $-45 |
| 2021-09-30 | $-33 |
| 2021-06-30 | $-61 |
| 2021-03-31 | $4 |
| 2020-12-31 | $-87 |
| 2020-09-30 | $-7 |
| 2020-06-30 | $-6 |
| 2020-03-31 | $-4 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.278B | $0.000B |
| atai Life Sciences B.V. is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. atai Life Sciences B.V. is based in BERLIN. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quest Diagnostics (DGX) | United States | $19.755B | 19.47 |
| Encompass Health (EHC) | United States | $11.734B | 24.87 |
| DaVita (DVA) | United States | $11.050B | 14.67 |
| Chemed (CHE) | United States | $8.342B | 26.22 |
| Elanco Animal Health (ELAN) | United States | $5.940B | 12.72 |
| Option Care Health (OPCH) | United States | $5.214B | 23.24 |
| RadNet (RDNT) | United States | $4.181B | 88.48 |
| Amedisys (AMED) | United States | $3.128B | 21.04 |
| LifeStance Health (LFST) | United States | $2.228B | 0.00 |
| Addus HomeCare (ADUS) | United States | $2.041B | 22.41 |
| Astrana Health (ASTH) | United States | $1.666B | 41.26 |
| U.S Physical Therapy (USPH) | United States | $1.125B | 29.05 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.054B | 60.00 |
| Pennant (PNTG) | United States | $0.985B | 36.18 |
| Daxor (DXR) | United States | $0.037B | 0.00 |
| Ontrak (OTRK) | United States | $0.007B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.005B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |